We are frequently asked for comment, insight and articles by media organisations and specialist pharmaceutical journals, particularly when there are notable industry-influencing events

See below for a selection of our most recent media activity, and explore our White Papers for more in-depth analysis

Bayer settles but is its future path clear? (Deutsche Welle)

News image Discover

Is a mega merger the best option? (CNBC)

News image Discover

AstraZeneca eyes up Gilead (Bloomberg)

News image Discover

Pharma frenemies (The Economist)

News image Discover

Continued innovation pays for Big Pharma (CNBC)

News image Discover

Strategic focus allows Novartis to raise sales targets (CNBC)

News image Discover

New chief aims to revive Sanofi (Bloomberg)

News image Discover

Patent Panic Gives Green Light to Deals (Financial Times)

News image Discover

AbbVie and Allergan: not an A* Deal (CNBC)

News image Discover

Roundup verdict (Deutsche Welle)

News image Discover

AstraZeneca: Big Pharma to Big Biotech (Bloomberg)

News image Discover

Agrochemicals and pharma are not compatible (Die Zeit)

News image Discover

Brexit poses threats beyond supply chains (Bloomberg)

News image Discover

Mega-mergers are not the solution for pharma (CNBC)

News image Discover

The perils of pharma mega-mergers (Bloomberg)

News image Discover

GSK’s increased focus on innovative pharma (CNBC)

News image Discover

Novartis, innovation and acquisitions in Big Pharma (CNBC)

News image Discover

Big pharma M&A battleground (CNBC)
.

News image Discover

Takeda CEO prescribes R&D cuts after Shire deal (Reuters)

News image Discover

Takeda's takeover of Shire (CNBC)

News image Discover

GSK-Novartis consumer health care deal (CNBC)

News image Discover

GSK withdraws from Consumer-Health bid (Bloomberg)

News image Discover

Sanofi-Ablynx deal (CNBC)

News image Discover

Sanofi and Celgene announce deals (Bloomberg)

News image Discover

GSK responds to AstraZeneca threat (Bloomberg)

News image Discover

Pharma outlook 2018 (CNBC)
.

News image Discover

The perils of pharma M&A (Bloomberg)

News image Discover

Another Roche setback (CNBC)
.

News image Discover

Turning world-leading science into medicines (Daily Telegraph)

News image Discover

EU probe Bayer’s proposed merger (CNBC)

News image Discover

GSK's evolving business model (Daily Telegraph)

News image Discover

Novartis’ Gene Therapy progress (CNBC)

News image Discover

Roche’s oncology setback (CNBC)
.

News image Discover

What the American Health Care Act could mean for pharma (CNBC)

News image Discover

Bayer’s outlook following its recent acquisition (CNBC)

News image Discover

Private equity firms bid on Stada (In Vivo)

News image Discover

Sanofi CEO hopes for positive results (Scrip)

News image Discover

GSK's prospects (CNBC)

News image Discover

Pharma outlook 2017 (CNBC)
.

News image Discover

J&J and Actelion point to the industry’s future (CNBC, Scrip)

News image Discover

Recruitment in UK pharma sector harder post-Brexit (Daily Telegraph)

News image Discover

Actelion exploring strategic transaction (Bloomberg)

News image Discover

Pfizer fined for price hike (Daily Telegraph)

News image Discover

Sweden vies for the EMA post-Brexit (Daily Telegraph)

News image Discover

Increased UK funding for science and tech (Reuters)

News image Discover

GSK's and Bayer's Q3 results (Bloomberg)

News image Discover

Pharma investor perspectives (CNBC)
.

News image Discover

Brexit: ABPI/BIA report (Daily Telegraph)

News image Discover

GSK’s new CEO (Reuters)

News image Discover

The future for Bayer (CNBC)
.

News image Discover

Bayer’s M&A activity (CNBC)
.

News image Discover

From mid-cap to Big Pharma: the challenge for Shire (The Times)

News image Discover

Risks for UK Biotech (The Times)

News image Discover

Cost of pharma M&A doubles (Financial Times)

News image Discover

Why Private Equity is Investing in Biopharma (MedNous)

News image Discover

A strategy for using AI in pharma R&D (MedNous)

News image Discover

Keeping it in the family pays dividends (PME)

News image Discover

How to overcome microbial resistance (Labiotech)

News image Discover

Cheap capital gives rise to integrated pharma R&D (MedNous)

News image Discover

Raising capital: how biotech can avoid the risks (The Pharma Letter)

News image Discover

Brexit research published (In Vivo)

News image Discover

Novasecta's Perspective on Brexit (Biotech and Money)

News image Discover

The year British biotechs will come of age (The Pharma Letter)

News image Discover

Pharma and academia are natural partners for R&D (MedNous)

News image Discover

Why the time has come for MidPharmas (MedNous)

News image Discover

Understanding and Choosing Your Partner (One Nucleus)

News image Discover

Resources

Insights

Insight

Our perspectives and analysis on topical industry issues

Find Out More

Case studies

Case studies

Discover what our clients have achieved with us, and how

Find Out More